loadpatents
name:-0.0083498954772949
name:-0.002918004989624
name:-0.0086688995361328
RAMANN; Ginelle A. Patent Filings

RAMANN; Ginelle A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for RAMANN; Ginelle A..The latest application filed is for "fused heterocyclic compounds as ret kinase inhibitors".

Company Profile
8.4.8
  • RAMANN; Ginelle A. - Indianapolis IN
  • Ramann; Ginelle A. - Boulder CO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused Heterocyclic Compounds As Ret Kinase Inhibitors
App 20220112214 - BLAKE; James F. ;   et al.
2022-04-14
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,881,652 - Andrews , et al. January 5, 2
2021-01-05
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20200383966 - ANDREWS; Steven W. ;   et al.
2020-12-10
Substituted Pyrazolyl[4,3-c]pyridine Compounds As Ret Kinase Inhibitors
App 20200339579 - WALLS; Shane M. ;   et al.
2020-10-29
Substituted Pyrrolo[2,3-d]pyrimidines Compounds As Ret Kinase Inhibitors
App 20200339589 - BLAKE; James F. ;   et al.
2020-10-29
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20200030311 - ANDREWS; Steven W. ;   et al.
2020-01-30
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,441,581 - Andrews , et al. Oc
2019-10-15
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,172,845 - Andrews , et al. J
2019-01-08
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
Grant 10,144,734 - Andrews , et al. De
2018-12-04
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180148445 - Andrews; Steven W. ;   et al.
2018-05-31
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180133207 - Andrews; Steven W. ;   et al.
2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors
App 20180134703 - Andrews; Steven W. ;   et al.
2018-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed